The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of a DNA damage response deficiency (DDRD) assay with prognosis in resected esophageal and gastric adenocarcinoma.
 
Richard C. Turkington
Honoraria - Lilly
 
Laura A Knight
Employment - Almac Diagnostics
 
Rosalie V. Douglas
No Relationships to Disclose
 
Jaine K. Blayney
No Relationships to Disclose
 
Leanne Stevenson
No Relationships to Disclose
 
Damian McManus
No Relationships to Disclose
 
Andrena McCavigan
Employment - Almac Diagnostics
 
Steven M. Walker
Employment - Almac Diagnostics
 
Jan Bornschein
No Relationships to Disclose
 
Shona MacRae
No Relationships to Disclose
 
Fergus Noble
No Relationships to Disclose
 
Timothy J Underwood
No Relationships to Disclose
 
Robert O'Neill
No Relationships to Disclose
 
Stephen McQuaid
No Relationships to Disclose
 
Ken Arthur
No Relationships to Disclose
 
Jacqueline James
No Relationships to Disclose
 
Martin McKinlay Eatock
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly
Research Funding - Boston Biomedical; Merrimack
 
Paul D Harkin
Employment - Almac Diagnostics
 
Rebecca C. Fitzgerald
Research Funding - Covidien/Medtronic
 
Richard D. Kennedy
Employment - Almac Diagnostics
Patents, Royalties, Other Intellectual Property - I am an author on the colon cancer prognostic COLDx assay patent